Correlation Between Dermata Therapeutics and NeuroSense Therapeutics
Can any of the company-specific risk be diversified away by investing in both Dermata Therapeutics and NeuroSense Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dermata Therapeutics and NeuroSense Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dermata Therapeutics Warrant and NeuroSense Therapeutics Ltd, you can compare the effects of market volatilities on Dermata Therapeutics and NeuroSense Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dermata Therapeutics with a short position of NeuroSense Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dermata Therapeutics and NeuroSense Therapeutics.
Diversification Opportunities for Dermata Therapeutics and NeuroSense Therapeutics
0.19 | Correlation Coefficient |
Average diversification
The 3 months correlation between Dermata and NeuroSense is 0.19. Overlapping area represents the amount of risk that can be diversified away by holding Dermata Therapeutics Warrant and NeuroSense Therapeutics Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NeuroSense Therapeutics and Dermata Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dermata Therapeutics Warrant are associated (or correlated) with NeuroSense Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NeuroSense Therapeutics has no effect on the direction of Dermata Therapeutics i.e., Dermata Therapeutics and NeuroSense Therapeutics go up and down completely randomly.
Pair Corralation between Dermata Therapeutics and NeuroSense Therapeutics
Assuming the 90 days horizon Dermata Therapeutics Warrant is expected to generate 1.46 times more return on investment than NeuroSense Therapeutics. However, Dermata Therapeutics is 1.46 times more volatile than NeuroSense Therapeutics Ltd. It trades about 0.15 of its potential returns per unit of risk. NeuroSense Therapeutics Ltd is currently generating about 0.1 per unit of risk. If you would invest 6.35 in Dermata Therapeutics Warrant on November 2, 2024 and sell it today you would lose (3.38) from holding Dermata Therapeutics Warrant or give up 53.23% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 77.07% |
| Values | Daily Returns |
Dermata Therapeutics Warrant vs. NeuroSense Therapeutics Ltd
Performance |
| Timeline |
| Dermata Therapeutics |
| NeuroSense Therapeutics |
Dermata Therapeutics and NeuroSense Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Dermata Therapeutics and NeuroSense Therapeutics
The main advantage of trading using opposite Dermata Therapeutics and NeuroSense Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dermata Therapeutics position performs unexpectedly, NeuroSense Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NeuroSense Therapeutics will offset losses from the drop in NeuroSense Therapeutics' long position.The idea behind Dermata Therapeutics Warrant and NeuroSense Therapeutics Ltd pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| NeuroSense Therapeutics vs. Neurosense Therapeutics | NeuroSense Therapeutics vs. GeoVax Labs | NeuroSense Therapeutics vs. NLS Pharmaceutics AG | NeuroSense Therapeutics vs. Cingulate Warrants |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Transaction History View history of all your transactions and understand their impact on performance | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |